alpha-naphthyl isocyanate has been researched along with Chronic Illness in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, L; Dai, M; Hu, X; Hua, H; Lin, H; Liu, A; Luo, Y; Tang, Z; Xu, G; Xu, L; Yang, J; Zhang, H | 1 |
1 other study(ies) available for alpha-naphthyl isocyanate and Chronic Illness
| Article | Year |
|---|---|
Basal PPARα inhibits bile acid metabolism adaptation in chronic cholestatic model induced by α-naphthylisothiocyanate.
Topics: Animals; Bile Acids and Salts; Chemical and Drug Induced Liver Injury; Cholestasis; Chronic Disease; Genetic Variation; Isocyanates; Liver; Male; Mice; Mice, Knockout; Naphthalenes; Phenotype | 2019 |